nodes	percent_of_prediction	percent_of_DWPC	metapath
Enoxaparin—MPO—urinary bladder cancer	0.568	1	CbGaD
Enoxaparin—MPO—Carboplatin—urinary bladder cancer	0.177	0.539	CbGbCtD
Enoxaparin—MPO—Cisplatin—urinary bladder cancer	0.151	0.461	CbGbCtD
Enoxaparin—F10—prostate gland—urinary bladder cancer	0.00172	0.252	CbGeAlD
Enoxaparin—F10—urethra—urinary bladder cancer	0.00115	0.168	CbGeAlD
Enoxaparin—F10—female reproductive system—urinary bladder cancer	0.000942	0.137	CbGeAlD
Enoxaparin—F10—vagina—urinary bladder cancer	0.000852	0.124	CbGeAlD
Enoxaparin—MPO—epithelium—urinary bladder cancer	0.000692	0.101	CbGeAlD
Enoxaparin—MPO—renal system—urinary bladder cancer	0.000642	0.0936	CbGeAlD
Enoxaparin—F10—lymph node—urinary bladder cancer	0.000551	0.0803	CbGeAlD
Enoxaparin—Local reaction—Epirubicin—urinary bladder cancer	0.000524	0.00548	CcSEcCtD
Enoxaparin—Vesiculobullous rash—Epirubicin—urinary bladder cancer	0.000517	0.00541	CcSEcCtD
Enoxaparin—Confusional state—Mitomycin—urinary bladder cancer	0.000515	0.00539	CcSEcCtD
Enoxaparin—Oedema—Mitomycin—urinary bladder cancer	0.000511	0.00534	CcSEcCtD
Enoxaparin—Diarrhoea—Valrubicin—urinary bladder cancer	0.000508	0.00531	CcSEcCtD
Enoxaparin—Shock—Mitomycin—urinary bladder cancer	0.000503	0.00526	CcSEcCtD
Enoxaparin—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0005	0.00523	CcSEcCtD
Enoxaparin—Skin exfoliation—Etoposide—urinary bladder cancer	0.000494	0.00517	CcSEcCtD
Enoxaparin—Local reaction—Doxorubicin—urinary bladder cancer	0.000485	0.00507	CcSEcCtD
Enoxaparin—Vesiculobullous rash—Doxorubicin—urinary bladder cancer	0.000479	0.00501	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Thiotepa—urinary bladder cancer	0.000471	0.00492	CcSEcCtD
Enoxaparin—Thrombocytosis—Epirubicin—urinary bladder cancer	0.000466	0.00488	CcSEcCtD
Enoxaparin—Headache—Valrubicin—urinary bladder cancer	0.000465	0.00486	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.000461	0.00482	CcSEcCtD
Enoxaparin—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.00046	0.00481	CcSEcCtD
Enoxaparin—Dyspnoea—Mitomycin—urinary bladder cancer	0.000456	0.00476	CcSEcCtD
Enoxaparin—Liver disorder—Methotrexate—urinary bladder cancer	0.000455	0.00475	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.000454	0.00475	CcSEcCtD
Enoxaparin—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.000453	0.00473	CcSEcCtD
Enoxaparin—Cardiac failure—Gemcitabine—urinary bladder cancer	0.000451	0.00471	CcSEcCtD
Enoxaparin—Paralysis—Methotrexate—urinary bladder cancer	0.000446	0.00466	CcSEcCtD
Enoxaparin—Cardiac failure—Fluorouracil—urinary bladder cancer	0.000443	0.00463	CcSEcCtD
Enoxaparin—Nausea—Valrubicin—urinary bladder cancer	0.000441	0.00461	CcSEcCtD
Enoxaparin—Pain—Mitomycin—urinary bladder cancer	0.000437	0.00457	CcSEcCtD
Enoxaparin—Thrombocytosis—Doxorubicin—urinary bladder cancer	0.000432	0.00451	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.000424	0.00443	CcSEcCtD
Enoxaparin—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000421	0.0044	CcSEcCtD
Enoxaparin—Paralysis—Epirubicin—urinary bladder cancer	0.000417	0.00436	CcSEcCtD
Enoxaparin—Thrombosis—Epirubicin—urinary bladder cancer	0.00041	0.00428	CcSEcCtD
Enoxaparin—Pneumonia—Thiotepa—urinary bladder cancer	0.000405	0.00424	CcSEcCtD
Enoxaparin—Body temperature increased—Mitomycin—urinary bladder cancer	0.000404	0.00422	CcSEcCtD
Enoxaparin—Hyperlipidaemia—Epirubicin—urinary bladder cancer	0.000402	0.00421	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.000396	0.00414	CcSEcCtD
Enoxaparin—Dermatitis atopic—Epirubicin—urinary bladder cancer	0.000392	0.0041	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.000388	0.00406	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.000388	0.00406	CcSEcCtD
Enoxaparin—Paralysis—Doxorubicin—urinary bladder cancer	0.000386	0.00404	CcSEcCtD
Enoxaparin—Cardiac failure—Etoposide—urinary bladder cancer	0.000385	0.00402	CcSEcCtD
Enoxaparin—Haematuria—Thiotepa—urinary bladder cancer	0.000384	0.00402	CcSEcCtD
Enoxaparin—Thrombosis—Doxorubicin—urinary bladder cancer	0.000379	0.00396	CcSEcCtD
Enoxaparin—Hyperlipidaemia—Doxorubicin—urinary bladder cancer	0.000372	0.00389	CcSEcCtD
Enoxaparin—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00037	0.00387	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.000369	0.00386	CcSEcCtD
Enoxaparin—Rash pustular—Epirubicin—urinary bladder cancer	0.000364	0.0038	CcSEcCtD
Enoxaparin—Haemoglobin—Thiotepa—urinary bladder cancer	0.000364	0.0038	CcSEcCtD
Enoxaparin—Dermatitis atopic—Doxorubicin—urinary bladder cancer	0.000363	0.00379	CcSEcCtD
Enoxaparin—Haemorrhage—Thiotepa—urinary bladder cancer	0.000362	0.00378	CcSEcCtD
Enoxaparin—Injection site pain—Epirubicin—urinary bladder cancer	0.000355	0.00371	CcSEcCtD
Enoxaparin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00035	0.00366	CcSEcCtD
Enoxaparin—Pneumonia—Gemcitabine—urinary bladder cancer	0.000341	0.00356	CcSEcCtD
Enoxaparin—Rash pustular—Doxorubicin—urinary bladder cancer	0.000336	0.00352	CcSEcCtD
Enoxaparin—Pneumonia—Fluorouracil—urinary bladder cancer	0.000335	0.0035	CcSEcCtD
Enoxaparin—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000332	0.00347	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.000331	0.00346	CcSEcCtD
Enoxaparin—Injection site pain—Doxorubicin—urinary bladder cancer	0.000329	0.00344	CcSEcCtD
Enoxaparin—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000327	0.00342	CcSEcCtD
Enoxaparin—Haematuria—Gemcitabine—urinary bladder cancer	0.000323	0.00338	CcSEcCtD
Enoxaparin—Headache—Mitomycin—urinary bladder cancer	0.00032	0.00335	CcSEcCtD
Enoxaparin—Alopecia—Thiotepa—urinary bladder cancer	0.00032	0.00334	CcSEcCtD
Enoxaparin—Inflammation—Methotrexate—urinary bladder cancer	0.00032	0.00334	CcSEcCtD
Enoxaparin—Vasculitis—Methotrexate—urinary bladder cancer	0.000318	0.00332	CcSEcCtD
Enoxaparin—Erythema—Thiotepa—urinary bladder cancer	0.000315	0.00329	CcSEcCtD
Enoxaparin—Myocardial infarction—Cisplatin—urinary bladder cancer	0.00031	0.00324	CcSEcCtD
Enoxaparin—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000306	0.0032	CcSEcCtD
Enoxaparin—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000304	0.00318	CcSEcCtD
Enoxaparin—Nausea—Mitomycin—urinary bladder cancer	0.000304	0.00317	CcSEcCtD
Enoxaparin—MPO—lymph node—urinary bladder cancer	0.000301	0.0439	CbGeAlD
Enoxaparin—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000301	0.00314	CcSEcCtD
Enoxaparin—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.0003	0.00313	CcSEcCtD
Enoxaparin—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000299	0.00313	CcSEcCtD
Enoxaparin—Inflammation—Epirubicin—urinary bladder cancer	0.000299	0.00313	CcSEcCtD
Enoxaparin—Skin exfoliation—Methotrexate—urinary bladder cancer	0.000296	0.00309	CcSEcCtD
Enoxaparin—Pneumonia—Etoposide—urinary bladder cancer	0.000291	0.00304	CcSEcCtD
Enoxaparin—Anaemia—Thiotepa—urinary bladder cancer	0.000291	0.00304	CcSEcCtD
Enoxaparin—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.00029	0.00303	CcSEcCtD
Enoxaparin—Hyperkalaemia—Epirubicin—urinary bladder cancer	0.000285	0.00298	CcSEcCtD
Enoxaparin—Myocardial infarction—Etoposide—urinary bladder cancer	0.000284	0.00297	CcSEcCtD
Enoxaparin—Ecchymosis—Methotrexate—urinary bladder cancer	0.00028	0.00293	CcSEcCtD
Enoxaparin—Skin exfoliation—Epirubicin—urinary bladder cancer	0.000277	0.0029	CcSEcCtD
Enoxaparin—Inflammation—Doxorubicin—urinary bladder cancer	0.000277	0.00289	CcSEcCtD
Enoxaparin—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.000276	0.00288	CcSEcCtD
Enoxaparin—Alopecia—Gemcitabine—urinary bladder cancer	0.000269	0.00281	CcSEcCtD
Enoxaparin—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.000268	0.00281	CcSEcCtD
Enoxaparin—Erythema—Gemcitabine—urinary bladder cancer	0.000265	0.00277	CcSEcCtD
Enoxaparin—Alopecia—Fluorouracil—urinary bladder cancer	0.000264	0.00276	CcSEcCtD
Enoxaparin—Hyperkalaemia—Doxorubicin—urinary bladder cancer	0.000264	0.00276	CcSEcCtD
Enoxaparin—Ecchymosis—Epirubicin—urinary bladder cancer	0.000262	0.00274	CcSEcCtD
Enoxaparin—Erythema—Fluorouracil—urinary bladder cancer	0.00026	0.00272	CcSEcCtD
Enoxaparin—Confusional state—Thiotepa—urinary bladder cancer	0.000259	0.00271	CcSEcCtD
Enoxaparin—Diabetes mellitus—Methotrexate—urinary bladder cancer	0.000259	0.0027	CcSEcCtD
Enoxaparin—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.000258	0.0027	CcSEcCtD
Enoxaparin—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.000256	0.00268	CcSEcCtD
Enoxaparin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000252	0.00263	CcSEcCtD
Enoxaparin—Alopecia—Cisplatin—urinary bladder cancer	0.000251	0.00262	CcSEcCtD
Enoxaparin—Erythema—Cisplatin—urinary bladder cancer	0.000247	0.00258	CcSEcCtD
Enoxaparin—Anaemia—Gemcitabine—urinary bladder cancer	0.000245	0.00256	CcSEcCtD
Enoxaparin—Ecchymosis—Doxorubicin—urinary bladder cancer	0.000243	0.00254	CcSEcCtD
Enoxaparin—Diabetes mellitus—Epirubicin—urinary bladder cancer	0.000242	0.00253	CcSEcCtD
Enoxaparin—Anaemia—Fluorouracil—urinary bladder cancer	0.000241	0.00252	CcSEcCtD
Enoxaparin—Malaise—Gemcitabine—urinary bladder cancer	0.000239	0.0025	CcSEcCtD
Enoxaparin—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.000239	0.0025	CcSEcCtD
Enoxaparin—Vascular purpura—Epirubicin—urinary bladder cancer	0.000235	0.00246	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.000232	0.00243	CcSEcCtD
Enoxaparin—Alopecia—Etoposide—urinary bladder cancer	0.00023	0.0024	CcSEcCtD
Enoxaparin—Anaemia—Cisplatin—urinary bladder cancer	0.000228	0.00239	CcSEcCtD
Enoxaparin—Diabetes mellitus—Doxorubicin—urinary bladder cancer	0.000224	0.00234	CcSEcCtD
Enoxaparin—Malaise—Cisplatin—urinary bladder cancer	0.000223	0.00233	CcSEcCtD
Enoxaparin—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00022	0.0023	CcSEcCtD
Enoxaparin—Pain—Thiotepa—urinary bladder cancer	0.00022	0.0023	CcSEcCtD
Enoxaparin—Purpura—Epirubicin—urinary bladder cancer	0.000218	0.00228	CcSEcCtD
Enoxaparin—Vascular purpura—Doxorubicin—urinary bladder cancer	0.000218	0.00228	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.000218	0.00227	CcSEcCtD
Enoxaparin—Oedema—Gemcitabine—urinary bladder cancer	0.000216	0.00226	CcSEcCtD
Enoxaparin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000216	0.00226	CcSEcCtD
Enoxaparin—Cardiac failure—Epirubicin—urinary bladder cancer	0.000216	0.00226	CcSEcCtD
Enoxaparin—Confusional state—Fluorouracil—urinary bladder cancer	0.000214	0.00224	CcSEcCtD
Enoxaparin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000213	0.00222	CcSEcCtD
Enoxaparin—Oedema—Fluorouracil—urinary bladder cancer	0.000213	0.00222	CcSEcCtD
Enoxaparin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000212	0.00221	CcSEcCtD
Enoxaparin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000212	0.00221	CcSEcCtD
Enoxaparin—Anaemia—Etoposide—urinary bladder cancer	0.000209	0.00219	CcSEcCtD
Enoxaparin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000208	0.00218	CcSEcCtD
Enoxaparin—Urticaria—Thiotepa—urinary bladder cancer	0.000204	0.00213	CcSEcCtD
Enoxaparin—Malaise—Etoposide—urinary bladder cancer	0.000204	0.00213	CcSEcCtD
Enoxaparin—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.000204	0.00213	CcSEcCtD
Enoxaparin—Body temperature increased—Thiotepa—urinary bladder cancer	0.000203	0.00212	CcSEcCtD
Enoxaparin—Purpura—Doxorubicin—urinary bladder cancer	0.000202	0.00211	CcSEcCtD
Enoxaparin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000202	0.00211	CcSEcCtD
Enoxaparin—Oedema—Cisplatin—urinary bladder cancer	0.000202	0.00211	CcSEcCtD
Enoxaparin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.000201	0.0021	CcSEcCtD
Enoxaparin—Cardiac failure—Doxorubicin—urinary bladder cancer	0.0002	0.00209	CcSEcCtD
Enoxaparin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000197	0.00206	CcSEcCtD
Enoxaparin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000193	0.00202	CcSEcCtD
Enoxaparin—Eosinophilia—Methotrexate—urinary bladder cancer	0.000193	0.00201	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.00019	0.00198	CcSEcCtD
Enoxaparin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00019	0.00198	CcSEcCtD
Enoxaparin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000189	0.00198	CcSEcCtD
Enoxaparin—Confusional state—Etoposide—urinary bladder cancer	0.000186	0.00195	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000186	0.00194	CcSEcCtD
Enoxaparin—Pain—Gemcitabine—urinary bladder cancer	0.000185	0.00193	CcSEcCtD
Enoxaparin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000185	0.00193	CcSEcCtD
Enoxaparin—Pruritus—Thiotepa—urinary bladder cancer	0.000182	0.0019	CcSEcCtD
Enoxaparin—Pain—Fluorouracil—urinary bladder cancer	0.000182	0.0019	CcSEcCtD
Enoxaparin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000181	0.00189	CcSEcCtD
Enoxaparin—Eosinophilia—Epirubicin—urinary bladder cancer	0.00018	0.00188	CcSEcCtD
Enoxaparin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00018	0.00188	CcSEcCtD
Enoxaparin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000178	0.00186	CcSEcCtD
Enoxaparin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000176	0.00184	CcSEcCtD
Enoxaparin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000175	0.00183	CcSEcCtD
Enoxaparin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000175	0.00183	CcSEcCtD
Enoxaparin—Pneumonia—Methotrexate—urinary bladder cancer	0.000174	0.00182	CcSEcCtD
Enoxaparin—Pain—Cisplatin—urinary bladder cancer	0.000172	0.0018	CcSEcCtD
Enoxaparin—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000172	0.0018	CcSEcCtD
Enoxaparin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000171	0.00179	CcSEcCtD
Enoxaparin—Urticaria—Fluorouracil—urinary bladder cancer	0.000169	0.00177	CcSEcCtD
Enoxaparin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000168	0.00176	CcSEcCtD
Enoxaparin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000167	0.00174	CcSEcCtD
Enoxaparin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000166	0.00174	CcSEcCtD
Enoxaparin—Haematuria—Methotrexate—urinary bladder cancer	0.000165	0.00173	CcSEcCtD
Enoxaparin—Dyspnoea—Etoposide—urinary bladder cancer	0.000165	0.00172	CcSEcCtD
Enoxaparin—Pneumonia—Epirubicin—urinary bladder cancer	0.000163	0.00171	CcSEcCtD
Enoxaparin—Headache—Thiotepa—urinary bladder cancer	0.000161	0.00168	CcSEcCtD
Enoxaparin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000159	0.00167	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.000158	0.0819	CbGpPWpGaD
Enoxaparin—Pain—Etoposide—urinary bladder cancer	0.000158	0.00165	CcSEcCtD
Enoxaparin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000157	0.00164	CcSEcCtD
Enoxaparin—Haemoglobin—Methotrexate—urinary bladder cancer	0.000156	0.00164	CcSEcCtD
Enoxaparin—Haemorrhage—Methotrexate—urinary bladder cancer	0.000156	0.00163	CcSEcCtD
Enoxaparin—Haematuria—Epirubicin—urinary bladder cancer	0.000155	0.00162	CcSEcCtD
Enoxaparin—Pruritus—Gemcitabine—urinary bladder cancer	0.000153	0.0016	CcSEcCtD
Enoxaparin—Nausea—Thiotepa—urinary bladder cancer	0.000153	0.0016	CcSEcCtD
Enoxaparin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000152	0.00159	CcSEcCtD
Enoxaparin—Pneumonia—Doxorubicin—urinary bladder cancer	0.000151	0.00158	CcSEcCtD
Enoxaparin—Pruritus—Fluorouracil—urinary bladder cancer	0.00015	0.00157	CcSEcCtD
Enoxaparin—MPO—Folate Metabolism—SLC19A1—urinary bladder cancer	0.000149	0.0772	CbGpPWpGaD
Enoxaparin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000148	0.00155	CcSEcCtD
Enoxaparin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000148	0.00155	CcSEcCtD
Enoxaparin—Urticaria—Etoposide—urinary bladder cancer	0.000147	0.00153	CcSEcCtD
Enoxaparin—Haemoglobin—Epirubicin—urinary bladder cancer	0.000146	0.00153	CcSEcCtD
Enoxaparin—Body temperature increased—Etoposide—urinary bladder cancer	0.000146	0.00153	CcSEcCtD
Enoxaparin—Haemorrhage—Epirubicin—urinary bladder cancer	0.000146	0.00152	CcSEcCtD
Enoxaparin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000145	0.00152	CcSEcCtD
Enoxaparin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000143	0.0015	CcSEcCtD
Enoxaparin—Haematuria—Doxorubicin—urinary bladder cancer	0.000143	0.0015	CcSEcCtD
Enoxaparin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000138	0.00144	CcSEcCtD
Enoxaparin—Alopecia—Methotrexate—urinary bladder cancer	0.000138	0.00144	CcSEcCtD
Enoxaparin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000136	0.00142	CcSEcCtD
Enoxaparin—Erythema—Methotrexate—urinary bladder cancer	0.000135	0.00142	CcSEcCtD
Enoxaparin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000135	0.00142	CcSEcCtD
Enoxaparin—Headache—Gemcitabine—urinary bladder cancer	0.000135	0.00142	CcSEcCtD
Enoxaparin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000135	0.00141	CcSEcCtD
Enoxaparin—Headache—Fluorouracil—urinary bladder cancer	0.000133	0.00139	CcSEcCtD
Enoxaparin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000133	0.00139	CcSEcCtD
Enoxaparin—Pruritus—Etoposide—urinary bladder cancer	0.000131	0.00137	CcSEcCtD
Enoxaparin—Alopecia—Epirubicin—urinary bladder cancer	0.000129	0.00135	CcSEcCtD
Enoxaparin—Nausea—Gemcitabine—urinary bladder cancer	0.000128	0.00134	CcSEcCtD
Enoxaparin—Erythema—Epirubicin—urinary bladder cancer	0.000127	0.00133	CcSEcCtD
Enoxaparin—Diarrhoea—Etoposide—urinary bladder cancer	0.000126	0.00132	CcSEcCtD
Enoxaparin—Nausea—Fluorouracil—urinary bladder cancer	0.000126	0.00132	CcSEcCtD
Enoxaparin—Anaemia—Methotrexate—urinary bladder cancer	0.000125	0.00131	CcSEcCtD
Enoxaparin—Malaise—Methotrexate—urinary bladder cancer	0.000122	0.00128	CcSEcCtD
Enoxaparin—Nausea—Cisplatin—urinary bladder cancer	0.00012	0.00125	CcSEcCtD
Enoxaparin—Alopecia—Doxorubicin—urinary bladder cancer	0.000119	0.00125	CcSEcCtD
Enoxaparin—Erythema—Doxorubicin—urinary bladder cancer	0.000117	0.00123	CcSEcCtD
Enoxaparin—Anaemia—Epirubicin—urinary bladder cancer	0.000117	0.00123	CcSEcCtD
Enoxaparin—Headache—Etoposide—urinary bladder cancer	0.000116	0.00121	CcSEcCtD
Enoxaparin—Malaise—Epirubicin—urinary bladder cancer	0.000114	0.0012	CcSEcCtD
Enoxaparin—F10—Blood Clotting Cascade—PLAU—urinary bladder cancer	0.000112	0.0581	CbGpPWpGaD
Enoxaparin—Confusional state—Methotrexate—urinary bladder cancer	0.000111	0.00117	CcSEcCtD
Enoxaparin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000111	0.00116	CcSEcCtD
Enoxaparin—Nausea—Etoposide—urinary bladder cancer	0.00011	0.00115	CcSEcCtD
Enoxaparin—Anaemia—Doxorubicin—urinary bladder cancer	0.000108	0.00113	CcSEcCtD
Enoxaparin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000108	0.00113	CcSEcCtD
Enoxaparin—Malaise—Doxorubicin—urinary bladder cancer	0.000106	0.00111	CcSEcCtD
Enoxaparin—Confusional state—Epirubicin—urinary bladder cancer	0.000104	0.00109	CcSEcCtD
Enoxaparin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000103	0.00108	CcSEcCtD
Enoxaparin—Oedema—Epirubicin—urinary bladder cancer	0.000103	0.00108	CcSEcCtD
Enoxaparin—Shock—Epirubicin—urinary bladder cancer	0.000102	0.00106	CcSEcCtD
Enoxaparin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000101	0.00106	CcSEcCtD
Enoxaparin—Dyspnoea—Methotrexate—urinary bladder cancer	9.86e-05	0.00103	CcSEcCtD
Enoxaparin—Confusional state—Doxorubicin—urinary bladder cancer	9.65e-05	0.00101	CcSEcCtD
Enoxaparin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	9.57e-05	0.001	CcSEcCtD
Enoxaparin—Oedema—Doxorubicin—urinary bladder cancer	9.57e-05	0.001	CcSEcCtD
Enoxaparin—SERPINC1—Glypican 1 network—SRC—urinary bladder cancer	9.48e-05	0.0492	CbGpPWpGaD
Enoxaparin—Pain—Methotrexate—urinary bladder cancer	9.46e-05	0.000989	CcSEcCtD
Enoxaparin—Shock—Doxorubicin—urinary bladder cancer	9.42e-05	0.000985	CcSEcCtD
Enoxaparin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	9.37e-05	0.00098	CcSEcCtD
Enoxaparin—Dyspnoea—Epirubicin—urinary bladder cancer	9.23e-05	0.000965	CcSEcCtD
Enoxaparin—Feeling abnormal—Methotrexate—urinary bladder cancer	9.11e-05	0.000953	CcSEcCtD
Enoxaparin—SERPINC1—Complement and Coagulation Cascades—PLAU—urinary bladder cancer	9.01e-05	0.0467	CbGpPWpGaD
Enoxaparin—F10—Beta2 integrin cell surface interactions—PLAU—urinary bladder cancer	8.98e-05	0.0466	CbGpPWpGaD
Enoxaparin—Pain—Epirubicin—urinary bladder cancer	8.85e-05	0.000925	CcSEcCtD
Enoxaparin—Urticaria—Methotrexate—urinary bladder cancer	8.78e-05	0.000918	CcSEcCtD
Enoxaparin—Body temperature increased—Methotrexate—urinary bladder cancer	8.74e-05	0.000914	CcSEcCtD
Enoxaparin—Dyspnoea—Doxorubicin—urinary bladder cancer	8.54e-05	0.000893	CcSEcCtD
Enoxaparin—Feeling abnormal—Epirubicin—urinary bladder cancer	8.53e-05	0.000892	CcSEcCtD
Enoxaparin—Urticaria—Epirubicin—urinary bladder cancer	8.22e-05	0.00086	CcSEcCtD
Enoxaparin—Pain—Doxorubicin—urinary bladder cancer	8.19e-05	0.000856	CcSEcCtD
Enoxaparin—Body temperature increased—Epirubicin—urinary bladder cancer	8.18e-05	0.000855	CcSEcCtD
Enoxaparin—Hypersensitivity—Methotrexate—urinary bladder cancer	8.15e-05	0.000852	CcSEcCtD
Enoxaparin—MPO—C-MYB transcription factor network—BIRC3—urinary bladder cancer	7.99e-05	0.0414	CbGpPWpGaD
Enoxaparin—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.89e-05	0.000825	CcSEcCtD
Enoxaparin—Pruritus—Methotrexate—urinary bladder cancer	7.82e-05	0.000818	CcSEcCtD
Enoxaparin—Hypersensitivity—Epirubicin—urinary bladder cancer	7.62e-05	0.000797	CcSEcCtD
Enoxaparin—Urticaria—Doxorubicin—urinary bladder cancer	7.61e-05	0.000795	CcSEcCtD
Enoxaparin—Body temperature increased—Doxorubicin—urinary bladder cancer	7.57e-05	0.000791	CcSEcCtD
Enoxaparin—Diarrhoea—Methotrexate—urinary bladder cancer	7.57e-05	0.000791	CcSEcCtD
Enoxaparin—Pruritus—Epirubicin—urinary bladder cancer	7.32e-05	0.000765	CcSEcCtD
Enoxaparin—Diarrhoea—Epirubicin—urinary bladder cancer	7.08e-05	0.00074	CcSEcCtD
Enoxaparin—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.05e-05	0.000738	CcSEcCtD
Enoxaparin—Headache—Methotrexate—urinary bladder cancer	6.93e-05	0.000724	CcSEcCtD
Enoxaparin—Pruritus—Doxorubicin—urinary bladder cancer	6.77e-05	0.000708	CcSEcCtD
Enoxaparin—Nausea—Methotrexate—urinary bladder cancer	6.57e-05	0.000687	CcSEcCtD
Enoxaparin—Diarrhoea—Doxorubicin—urinary bladder cancer	6.55e-05	0.000685	CcSEcCtD
Enoxaparin—Headache—Epirubicin—urinary bladder cancer	6.48e-05	0.000678	CcSEcCtD
Enoxaparin—MPO—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	6.4e-05	0.0332	CbGpPWpGaD
Enoxaparin—Nausea—Epirubicin—urinary bladder cancer	6.15e-05	0.000643	CcSEcCtD
Enoxaparin—Headache—Doxorubicin—urinary bladder cancer	6e-05	0.000627	CcSEcCtD
Enoxaparin—Nausea—Doxorubicin—urinary bladder cancer	5.69e-05	0.000595	CcSEcCtD
Enoxaparin—MPO—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	5.63e-05	0.0292	CbGpPWpGaD
Enoxaparin—MPO—Folate Metabolism—SOD2—urinary bladder cancer	5.2e-05	0.027	CbGpPWpGaD
Enoxaparin—F10—Complement and Coagulation Cascades—PLAU—urinary bladder cancer	5.09e-05	0.0264	CbGpPWpGaD
Enoxaparin—MPO—Folate Metabolism—GPX1—urinary bladder cancer	4.96e-05	0.0257	CbGpPWpGaD
Enoxaparin—MPO—Folate Metabolism—MTHFR—urinary bladder cancer	4.58e-05	0.0238	CbGpPWpGaD
Enoxaparin—MPO—IL23-mediated signaling events—IL2—urinary bladder cancer	4.3e-05	0.0223	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—GSTM1—urinary bladder cancer	4.27e-05	0.0222	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—NCOR1—urinary bladder cancer	4.27e-05	0.0222	CbGpPWpGaD
Enoxaparin—MPO—Selenium Micronutrient Network—SOD2—urinary bladder cancer	4.13e-05	0.0214	CbGpPWpGaD
Enoxaparin—MPO—Selenium Micronutrient Network—GPX1—urinary bladder cancer	3.94e-05	0.0204	CbGpPWpGaD
Enoxaparin—MPO—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	3.64e-05	0.0189	CbGpPWpGaD
Enoxaparin—MPO—IL23-mediated signaling events—TNF—urinary bladder cancer	3.13e-05	0.0163	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—CREBBP—urinary bladder cancer	2.94e-05	0.0153	CbGpPWpGaD
Enoxaparin—MPO—Folate Metabolism—IL2—urinary bladder cancer	2.71e-05	0.014	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	2.58e-05	0.0134	CbGpPWpGaD
Enoxaparin—MPO—Vitamin B12 Metabolism—TNF—urinary bladder cancer	2.42e-05	0.0126	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—PTGS2—urinary bladder cancer	2.41e-05	0.0125	CbGpPWpGaD
Enoxaparin—MPO—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	2.32e-05	0.012	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—IFNA2—urinary bladder cancer	2.27e-05	0.0118	CbGpPWpGaD
Enoxaparin—F10—Metabolism of proteins—CDX2—urinary bladder cancer	2.2e-05	0.0114	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—CCND1—urinary bladder cancer	2.18e-05	0.0113	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	2.11e-05	0.0109	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—EP300—urinary bladder cancer	2e-05	0.0104	CbGpPWpGaD
Enoxaparin—MPO—Folate Metabolism—TNF—urinary bladder cancer	1.97e-05	0.0102	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—MYC—urinary bladder cancer	1.75e-05	0.00906	CbGpPWpGaD
Enoxaparin—MPO—Folate Metabolism—TP53—urinary bladder cancer	1.74e-05	0.00902	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—PLAU—urinary bladder cancer	1.61e-05	0.00837	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—KRAS—urinary bladder cancer	1.61e-05	0.00837	CbGpPWpGaD
Enoxaparin—MPO—Selenium Micronutrient Network—TNF—urinary bladder cancer	1.57e-05	0.00813	CbGpPWpGaD
Enoxaparin—F10—Metabolism of proteins—IGFBP3—urinary bladder cancer	1.38e-05	0.00717	CbGpPWpGaD
Enoxaparin—MPO—C-MYB transcription factor network—HRAS—urinary bladder cancer	1.37e-05	0.00711	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—CREBBP—urinary bladder cancer	1.33e-05	0.00691	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—IGF1—urinary bladder cancer	1.32e-05	0.00682	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—IFNA2—urinary bladder cancer	1.29e-05	0.00667	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—RHOA—urinary bladder cancer	1.2e-05	0.00625	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—IL2—urinary bladder cancer	1.01e-05	0.00524	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—PLAU—urinary bladder cancer	9.12e-06	0.00473	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—EP300—urinary bladder cancer	9.07e-06	0.0047	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—SRC—urinary bladder cancer	8.82e-06	0.00457	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—CREBBP—urinary bladder cancer	7.52e-06	0.0039	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—IGF1—urinary bladder cancer	7.43e-06	0.00385	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—KRAS—urinary bladder cancer	7.3e-06	0.00379	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—RHOA—urinary bladder cancer	6.81e-06	0.00353	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—TP53—urinary bladder cancer	6.49e-06	0.00337	CbGpPWpGaD
Enoxaparin—SERPINC1—Hemostasis—HRAS—urinary bladder cancer	6.21e-06	0.00322	CbGpPWpGaD
Enoxaparin—F10—Metabolism of proteins—IGF1—urinary bladder cancer	5.85e-06	0.00303	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—IL2—urinary bladder cancer	5.71e-06	0.00296	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—EP300—urinary bladder cancer	5.12e-06	0.00266	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—SRC—urinary bladder cancer	4.98e-06	0.00258	CbGpPWpGaD
Enoxaparin—F10—Metabolism of proteins—CXCL8—urinary bladder cancer	4.7e-06	0.00244	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—KRAS—urinary bladder cancer	4.13e-06	0.00214	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—TP53—urinary bladder cancer	3.67e-06	0.0019	CbGpPWpGaD
Enoxaparin—F10—Hemostasis—HRAS—urinary bladder cancer	3.51e-06	0.00182	CbGpPWpGaD
